|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Inflammatory Bowel Disease Differentiation Panel
MessageThis test is currently only available in BHS CPRS. If you are a Bedford provider and wish to see this test offered in Bedford CPRS- please contact the Bedford Laboratory.
Testing performed at Quest Diagnostics.
Testing performed at Quest Diagnostics.
Test Code
INFLAMMATORY BOWEL DISEASE PANEL(Q)
CPT Codes
86021 (x2), 86036, 86671 (x2)
Includes
ANCA Screen with Reflex to ANCA Titer
Myeloperoxidase Antibody (MPO)
Proteinase-3 Antibody
Saccharomyces cerevisiae Antibodies (ASCA) (IgG)
Saccharomyces cerevisiae Antibodies (ASCA) (IgA)
If ANCA Screen is positive, then C-ANCA Titer and/or P-ANCA Titer, and/or atypical P-ANCA Titer will be performed at an additional charge (CPT code(s): 86037 for each titer performed).
Myeloperoxidase Antibody (MPO)
Proteinase-3 Antibody
Saccharomyces cerevisiae Antibodies (ASCA) (IgG)
Saccharomyces cerevisiae Antibodies (ASCA) (IgA)
If ANCA Screen is positive, then C-ANCA Titer and/or P-ANCA Titer, and/or atypical P-ANCA Titer will be performed at an additional charge (CPT code(s): 86037 for each titer performed).
Preferred Specimen
2 mL serum
Minimum Volume
1.4 mL
Transport Container
Plastic screw-cap vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 21 days
Refrigerated: 14 days
Frozen: 21 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Lipemia • Grossly icteric
Methodology
Immunoassay (IA)
Setup Schedule
Set up: Mon-Sat; Report available: 3-5 days
Reference Range
ANCA Screen | Negative |
P-ANCA Titer | <1:20 |
C-ANCA Titer | <1:20 |
Atypical P-ANCA Titer | <1:20 |
Myeloperoxidase Antibody
<1.0 AI | No antibody detected |
≥1.0 AI | Antibody detected |
Proteinase-3 Antibody
<1.0 AI | No antibody detected |
≥1.0 AI | Antibody detected |
Saccharomyces cerevisiae Ab (IgG)
≤20.0 U | Negative |
20.1-29.9 U | Equivocal |
≥30.0 U | Positive |
Saccharomyces cerevisiae Ab (IgA)
≤20.0 U | Negative |
20.1-24.9 U | Equivocal |
≥25.0 U | Positive |
Clinical Significance
This panel is useful in the diagnosis of Inflammatory Bowel diseases and can help to distinguish patients with ulcerative colitis from those with Crohn's Disease.
Last Updated: September 20, 2014